Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 18467316

Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Ann Oncol
Publication date
2008 Sep
First author
Chauffert B

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Chauffert B
      type
      Author
    2. name
      Mornex F
      type
      Author
    3. name
      Bonnetain F
      type
      Author
    4. name
      Rougier P
      type
      Author
    5. name
      Mariette C
      type
      Author
    6. name
      Bouché O
      type
      Author
    7. name
      Bosset JF
      type
      Author
    8. name
      Aparicio T
      type
      Author
    9. name
      Mineur L
      type
      Author
    10. name
      Azzedine A
      type
      Author
    11. name
      Hammel P
      type
      Author
    12. name
      Butel J
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Chauffert B
      type
      Author
    2. name
      Mornex F
      type
      Author
    3. name
      Bonnetain F
      type
      Author
    4. name
      Rougier P
      type
      Author
    5. name
      Mariette C
      type
      Author
    6. name
      Bouché O
      type
      Author
    7. name
      Bosset JF
      type
      Author
    8. name
      Aparicio T
      type
      Author
    9. name
      Mineur L
      type
      Author
    10. name
      Azzedine A
      type
      Author
    11. name
      Hammel P
      type
      Author
    12. name
      Butel J
      type
      Author
    bibliography ids
    1. nci-bib-04517ce55cb65ac0d59d4a54
    book metadata
    content sha256
    0aac92a8842a7675d0ae4da9ba8d66df4db9e0191714c79cf50379c683f314b4
    document type
    citation
    dois
    1. 10.1093/annonc/mdn281
    electronic publication date
    display
    2008 May 7
    precision
    day
    year
    2008
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:18467316
    immutable id
    pubmed:18467316@0aac92a8842a7675d0ae4da9ba8d66df4db9e0191714c79cf50379c683f314b4
    journal
    abbreviation
    Ann Oncol
    issn electronic
    1569-8041
    issn print
    0923-7534
    issue
    9
    name
    Annals of oncology : official journal of the European Society for Medical Oncology
    nlm unique id
    9007735
    pages
    1592-9
    volume
    19
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      18467316
      provenance
      batch id
      e663b4be92ee60a9b059
      provider
      NCBI PubMed ESummary
      record sha256
      c26e66fce5105aa2362071573b1efd94da8856a1195f0258d8c656df39bfe53e
      response sha256
      514286e846d1566a3f75c88a4af66b82adfc16ee2368b19bce657f2237aba90d
      retrieved at
      2026-09-09T23:46:19.265979+00:00
      publication date
      display
      2008 Sep
      precision
      month
      year
      2008
      publication types
      1. Clinical Trial, Phase III
      2. Comparative Study
      3. Journal Article
      4. Multicenter Study
      5. Randomized Controlled Trial
      6. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/18467316/
      title
      Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study.

      Preserved source evidence · Not medical advice